Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2015

01.05.2015 | Original Article

Fibromyalgia Symptoms and Cirrhosis

verfasst von: Shari S. Rogal, Klaus Bielefeldt, Ajay D. Wasan, Eva Szigethy, Francis Lotrich, Andrea F. DiMartini

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

An association between fibromyalgia and hepatitis C virus (HCV) has been previously described. However, the relationship between nonalcoholic steatohepatitis (NASH) and fibromyalgia symptoms has not been assessed, though they share several risk factors.

Aim

We aimed to assess the factors associated with fibromyalgia symptoms across etiologies of liver disease.

Methods

Patients with cirrhosis due to HCV, NASH, or alcohol were recruited from an outpatient hepatology clinic and administered the Hospital Anxiety and Depression Score, Pittsburgh Sleep Quality Index, and the modified 2010 American College of Rheumatology Diagnostic Criteria for Fibromyalgia. Serum inflammatory markers were measured with standard luminex assays.

Results

Of 193 participants, 53 (27 %) met criteria for fibromyalgia. Fibromyalgia symptoms were significantly associated with etiology of liver disease (HCV: 35 %, NASH: 30 %, alcohol-related liver disease: 12 %, p < 0.01). Using logistic regression, mood symptoms (OR 1.14, 95 % CI 1.06, 1.22), sleep disturbance (OR 1.32, 95 % CI 1.16, 1.52), and etiology of liver disease (NASH vs. HCV not different, alcohol vs. HCV OR 0.19, 95 % CI 0.05, 0.63) were associated with fibromyalgia symptoms. If abdominal pain was included in the model, etiology became nonsignificant, indicating that it may be central sensitization due to abdominal pain in patients with chronic liver disease that explains fibromyalgia symptoms rather than the etiology of liver disease or inflammation.

Conclusions

Fibromyalgia symptoms were significantly associated with HCV and NASH cirrhosis and with psychiatric symptoms. Future work should focus on the underlying pathophysiology and management of widespread pain in patients with cirrhosis.
Literatur
5.
Zurück zum Zitat Narvaez J, Nolla JM, Valverde-Garcia J. Lack of association of fibromyalgia with hepatitis C virus infection. J Rheumatol. 2005;32:1118–1121.PubMed Narvaez J, Nolla JM, Valverde-Garcia J. Lack of association of fibromyalgia with hepatitis C virus infection. J Rheumatol. 2005;32:1118–1121.PubMed
7.
8.
Zurück zum Zitat Diaz-Piedra C, Catena A, Miro E, Pilar Martinez M, Sanchez AI, Buela-Casal G. The impact of pain on anxiety and depression is mediated by objective and subjective sleep characteristics in fibromyalgia patients. Clin. J Pain. 2013. doi:10.1097/AJP.0000000000000040. Diaz-Piedra C, Catena A, Miro E, Pilar Martinez M, Sanchez AI, Buela-Casal G. The impact of pain on anxiety and depression is mediated by objective and subjective sleep characteristics in fibromyalgia patients. Clin. J Pain. 2013. doi:10.​1097/​AJP.​0000000000000040​.
12.
Zurück zum Zitat Torer N, Ozenirler S, Yucel A, Bukan N, Erdem O. Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis. Scand J Gastroenterol. 2007;42:1095–1101. doi:10.1080/00365520701286680.CrossRefPubMed Torer N, Ozenirler S, Yucel A, Bukan N, Erdem O. Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis. Scand J Gastroenterol. 2007;42:1095–1101. doi:10.​1080/​0036552070128668​0.CrossRefPubMed
19.
Zurück zum Zitat Rogal SS, Bielefeldt K, Wasan AD, et al. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with Cirrhosis. Clin Gastroenterol Hepatol. 2014 (in press). Rogal SS, Bielefeldt K, Wasan AD, et al. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with Cirrhosis. Clin Gastroenterol Hepatol. 2014 (in press).
20.
Zurück zum Zitat Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370.CrossRefPubMed Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370.CrossRefPubMed
21.
Zurück zum Zitat Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69–77.CrossRefPubMed Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69–77.CrossRefPubMed
22.
Zurück zum Zitat Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.CrossRefPubMed Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.CrossRefPubMed
23.
Zurück zum Zitat Osorio CD, Gallinaro AL, Lorenzi-Filho G, Lage LV. Sleep quality in patients with fibromyalgia using the Pittsburgh Sleep Quality Index. J Rheumatol. 2006;33:1863–1865.PubMed Osorio CD, Gallinaro AL, Lorenzi-Filho G, Lage LV. Sleep quality in patients with fibromyalgia using the Pittsburgh Sleep Quality Index. J Rheumatol. 2006;33:1863–1865.PubMed
24.
Zurück zum Zitat Buysse DJ, Hall ML, Strollo PJ, et al. Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med. 2008;4:563–571.PubMedCentralPubMed Buysse DJ, Hall ML, Strollo PJ, et al. Relationships between the Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and clinical/polysomnographic measures in a community sample. J Clin Sleep Med. 2008;4:563–571.PubMedCentralPubMed
25.
Zurück zum Zitat Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277–299.CrossRefPubMed Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277–299.CrossRefPubMed
26.
Zurück zum Zitat Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38:1113–1122. doi:10.3899/jrheum.100594.CrossRefPubMed Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38:1113–1122. doi:10.​3899/​jrheum.​100594.CrossRefPubMed
27.
Zurück zum Zitat Ferrari R, Russell AS. A questionnaire using the modified 2010 American College of Rheumatology criteria for fibromyalgia: specificity and sensitivity in clinical practice. J Rheumatol. 2013;40:1590–1595. doi:10.3899/jrheum.130367.CrossRefPubMed Ferrari R, Russell AS. A questionnaire using the modified 2010 American College of Rheumatology criteria for fibromyalgia: specificity and sensitivity in clinical practice. J Rheumatol. 2013;40:1590–1595. doi:10.​3899/​jrheum.​130367.CrossRefPubMed
28.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
29.
Zurück zum Zitat Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods. 2000;243:243–255.CrossRefPubMed Vignali DA. Multiplexed particle-based flow cytometric assays. J Immunol Methods. 2000;243:243–255.CrossRefPubMed
31.
Zurück zum Zitat Thompson ME, Barkhuizen A. Fibromyalgia, hepatitis C infection, and the cytokine connection. Curr Pain Headache Rep. 2003;7:342–347.CrossRefPubMed Thompson ME, Barkhuizen A. Fibromyalgia, hepatitis C infection, and the cytokine connection. Curr Pain Headache Rep. 2003;7:342–347.CrossRefPubMed
34.
Zurück zum Zitat Wang H, Moser M, Schiltenwolf M, Buchner M. Circulating cytokine levels compared to pain in patients with fibromyalgia—a prospective longitudinal study over 6 months. J Rheumatol. 2008;35:1366–1370.PubMed Wang H, Moser M, Schiltenwolf M, Buchner M. Circulating cytokine levels compared to pain in patients with fibromyalgia—a prospective longitudinal study over 6 months. J Rheumatol. 2008;35:1366–1370.PubMed
35.
Zurück zum Zitat Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology. 2001;40:743–749.CrossRefPubMed Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology. 2001;40:743–749.CrossRefPubMed
37.
Zurück zum Zitat Alfven G, de la Torre B, Uvnas-Moberg K. Depressed concentrations of oxytocin and cortisol in children with recurrent abdominal pain of non-organic origin. Acta Paediatr. 1994;83:1076–1080.CrossRefPubMed Alfven G, de la Torre B, Uvnas-Moberg K. Depressed concentrations of oxytocin and cortisol in children with recurrent abdominal pain of non-organic origin. Acta Paediatr. 1994;83:1076–1080.CrossRefPubMed
39.
Zurück zum Zitat Fede G, Spadaro L, Tomaselli T, et al. Comparison of total cortisol, free cortisol, and surrogate markers of free cortisol in diagnosis of adrenal insufficiency in patients with stable cirrhosis. Clin Gastroenterol Hepatol. 2013. doi:10.1016/j.cgh.2013.08.028.PubMed Fede G, Spadaro L, Tomaselli T, et al. Comparison of total cortisol, free cortisol, and surrogate markers of free cortisol in diagnosis of adrenal insufficiency in patients with stable cirrhosis. Clin Gastroenterol Hepatol. 2013. doi:10.​1016/​j.​cgh.​2013.​08.​028.PubMed
42.
Zurück zum Zitat Senna MK, Sallam RA, Ashour HS, Elarman M. Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial. Clin Rheumatol. 2012;31:1591–1597. doi:10.1007/s10067-012-2053-x.CrossRefPubMed Senna MK, Sallam RA, Ashour HS, Elarman M. Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial. Clin Rheumatol. 2012;31:1591–1597. doi:10.​1007/​s10067-012-2053-x.CrossRefPubMed
43.
Zurück zum Zitat Mork PJ, Vasseljen O, Nilsen TI. Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Trondelag Health Study. Arthritis Care Res. 2010;62:611–617. doi:10.1002/acr.20118.CrossRef Mork PJ, Vasseljen O, Nilsen TI. Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Trondelag Health Study. Arthritis Care Res. 2010;62:611–617. doi:10.​1002/​acr.​20118.CrossRef
44.
47.
Zurück zum Zitat Dwyer JP, Jayasekera C, Nicoll A. Analgesia for the Cirrhotic Patient: a literature review and recommendations. J Gastroenterol Hepatol. 2014. doi:10.1111/jgh.12560.PubMed Dwyer JP, Jayasekera C, Nicoll A. Analgesia for the Cirrhotic Patient: a literature review and recommendations. J Gastroenterol Hepatol. 2014. doi:10.​1111/​jgh.​12560.PubMed
Metadaten
Titel
Fibromyalgia Symptoms and Cirrhosis
verfasst von
Shari S. Rogal
Klaus Bielefeldt
Ajay D. Wasan
Eva Szigethy
Francis Lotrich
Andrea F. DiMartini
Publikationsdatum
01.05.2015
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2015
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3453-3

Weitere Artikel der Ausgabe 5/2015

Digestive Diseases and Sciences 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.